高级检索
当前位置: 首页 > 详情页

MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1

文献详情

资源类型:
机构: [1]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Otolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [2]Jinan Univ, Coll Life Sci & Technol, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med,Dept Cell Biol, Guangzhou, Guangdong, Peoples R China; [3]Jinan Univ, Coll Life Sci & Technol, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med,Inst Biomed, Guangzhou, Guangdong, Peoples R China; [4]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Pulm & Crit Care, Guangzhou, Guangdong, Peoples R China; [5]Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Dept Head & Neck, Guangzhou, Guangdong, Peoples R China; [6]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou, Guangdong, Peoples R China; [7]Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Dept Head & Neck Surg, Guangzhou, Guangdong, Peoples R China
出处:
ISSN:

关键词: Laryngeal squamous cell carcinoma miR-194 Wee1

摘要:
The emerging roles of microRNAs (miRs) have been deeply investigated in cancer. However, the role of miR-194 in human laryngeal squamous cell carcinoma (LSCC) is still unclear. Here, we have demonstrated that miR-194 is significantly downregulated in LSCC tissues and cells, and overexpression of miR-194 inhibits the proliferation, migration, invasion, and drug resistance in LSCC cells. Moreover, Wee1 is identified as a novel direct target of miR-194. Ectopic expression of Wee1 at least in part overcomes the suppressive impacts of miR-194 on the malignant phenotypes of LSCC. Overall, our study provides new sights into the role of miR-194/Wee1 axis in LSCC and suggests a novel miR-194/Wee1-based clinical application for LSCC patients.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 血液学 2 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 血液学 1 区 肿瘤学
第一作者:
第一作者机构: [1]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Otolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China;
通讯作者:
通讯机构: [1]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Otolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [2]Jinan Univ, Coll Life Sci & Technol, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med,Dept Cell Biol, Guangzhou, Guangdong, Peoples R China; [3]Jinan Univ, Coll Life Sci & Technol, Guangdong Prov Key Lab Bioengn Med, Natl Engn Res Ctr Genet Med,Inst Biomed, Guangzhou, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]α2δ1 may be a potential marker for cancer stem cell in laryngeal squamous cell carcinoma. [2]Epithelial cell transforming sequence 2 expression is associated with the progression of laryngeal squamous cell carcinoma. [3]FOXL2 expression might be a novel prognostic biomarker in patients with laryngeal squamous cell carcinoma [4]Metastasis of recurrent laryngeal nerve lymph nodes as a predictor of cervical lymph node metastasis in esophageal squamous cell carcinoma [5]DNA-dependent protein kinase catalytic subunit functions in metastasis and influences survival in advanced-stage laryngeal squamous cell carcinoma [6]LncRNA TP73-AS1 accelerates tumor progression in gastric cancer through regulating miR-194-5p/SDAD1 axis [7]Proteomic Characterization of Proliferation Inhibition of Well-Differentiated Laryngeal Squamous Cell Carcinoma Cells Under Below-Background Radiation in a Deep Underground Environment. [8]Improvement of image quality of laryngeal squamous cell carcinoma using noise-optimized virtual monoenergetic image and nonlinear blending image algorithms in dual-energy computed tomography [9]Loss of LKB1 Expression Decreases the Survival and Promotes Laryngeal Cancer Metastasis [10]Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号